Exclusion Criteria:~1. Screening MRI of the brain indicative of significant abnormality.~2. Clinically
significant abnormalities in screening laboratory tests.~3. Clinical or laboratory findings consistent with:~
1. Other primary degenerative dementia, (dementia with Lewy bodies, fronto-temporal dementia, Huntington's
disease, Creutzfeldt-Jakob Disease, Down syndrome, etc.).~ 2. Other neurodegenerative condition (Parkinson's
disease, amyotrophic lateral sclerosis, etc.).~ 3. Other infectious, metabolic or systemic diseases affecting
the central nervous system (syphilis, present hypothyroidism, present vitamin B12, other laboratory values
etc.)~4. A participant known to be actively infected with hepatitis B or hepatitis C at screening. History of
acute/chronic hepatitis B or C and/or carriers of hepatitis B (seropositive for hepatitis B surface antigen
\[HbsAg\] or anti-hepatitis C \[HCV\] antibody). Participants who have evidence of resolved hepatitis infection
(e.g., HCV RNA negative) may be considered following discussion with the Medical Monitor.~5. A current DSM-V
diagnosis of active major depression or GDS > 6, schizophrenia, or bipolar disorder.
